These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 28445958)

  • 1. Repressing CD147 is a novel therapeutic strategy for malignant melanoma.
    Hu X; Su J; Zhou Y; Xie X; Peng C; Yuan Z; Chen X
    Oncotarget; 2017 Apr; 8(15):25806-25813. PubMed ID: 28445958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD147/basigin promotes progression of malignant melanoma and other cancers.
    Kanekura T; Chen X
    J Dermatol Sci; 2010 Mar; 57(3):149-54. PubMed ID: 20060267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of CD147 induces malignant melanoma cell apoptosis via the regulation of IGFBP2 expression.
    Zhao S; Wu L; Kuang Y; Su J; Luo Z; Wang Y; Li J; Zhang J; Chen W; Li F; He Y; Tao J; Zhou J; Xu X; Peng C; Chen X
    Int J Oncol; 2018 Dec; 53(6):2397-2408. PubMed ID: 30272281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA interference targeting CD147 inhibits metastasis and invasion of human breast cancer MCF-7 cells by downregulating MMP-9/VEGF expression.
    Li F; Zhang J; Guo J; Jia Y; Han Y; Wang Z
    Acta Biochim Biophys Sin (Shanghai); 2018 Jul; 50(7):676-684. PubMed ID: 29901696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The phosphorylation of CD147 by Fyn plays a critical role for melanoma cells growth and metastasis.
    Zhang X; Huang Z; Guo Y; Xiao T; Tang L; Zhao S; Wu L; Su J; Zeng W; Huang H; Li Z; Tao J; Zhou J; Chen X; Peng C
    Oncogene; 2020 May; 39(21):4183-4197. PubMed ID: 32291412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting CD147 is a Novel Strategy for Antitumor Therapy.
    Lian C; Guo Y; Zhang J; Chen X; Peng C
    Curr Pharm Des; 2017 Nov; 23(29):4410-4421. PubMed ID: 28699528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol-induced apoptosis is associated with regulating the miR-492/CD147 pathway in malignant melanoma cells.
    Zhao S; Tang L; Chen W; Su J; Li F; Chen X; Wu L
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Apr; 394(4):797-807. PubMed ID: 33009925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD147 silencing inhibits tumor growth by suppressing glucose transport in melanoma.
    Su J; Gao T; Jiang M; Wu L; Zeng W; Zhao S; Peng C; Chen X
    Oncotarget; 2016 Oct; 7(40):64778-64784. PubMed ID: 27556188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel interaction between calcium-modulating cyclophilin ligand and Basigin regulates calcium signaling and matrix metalloproteinase activities in human melanoma cells.
    Long T; Su J; Tang W; Luo Z; Liu S; Liu Z; Zhou H; Qi M; Zeng W; Zhang J; Chen X
    Cancer Lett; 2013 Oct; 339(1):93-101. PubMed ID: 23879967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD147 interacts with NDUFS6 in regulating mitochondrial complex I activity and the mitochondrial apoptotic pathway in human malignant melanoma cells.
    Luo Z; Zeng W; Tang W; Long T; Zhang J; Xie X; Kuang Y; Chen M; Su J; Chen X
    Curr Mol Med; 2014; 14(10):1252-64. PubMed ID: 25470292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD147 regulates melanoma metastasis via the NFAT1-MMP-9 pathway.
    Liu N; Qi M; Li K; Zeng W; Li J; Yin M; Liu H; Chen X; Zhang J; Peng C
    Pigment Cell Melanoma Res; 2020 Sep; 33(5):731-743. PubMed ID: 32339381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A CD147-targeting siRNA inhibits the proliferation, invasiveness, and VEGF production of human malignant melanoma cells by down-regulating glycolysis.
    Su J; Chen X; Kanekura T
    Cancer Lett; 2009 Jan; 273(1):140-7. PubMed ID: 18778892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNAi-mediated silencing of CD147 inhibits tumor cell proliferation, invasion and increases chemosensitivity to cisplatin in SGC7901 cells in vitro.
    Wang B; Xu YF; He BS; Pan YQ; Zhang LR; Zhu C; Qu LL; Wang SK
    J Exp Clin Cancer Res; 2010 Jun; 29(1):61. PubMed ID: 20525232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basigin (CD147) is expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts.
    Kanekura T; Chen X; Kanzaki T
    Int J Cancer; 2002 Jun; 99(4):520-8. PubMed ID: 11992541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD147 promotes melanoma progression through hypoxia-induced MMP2 activation.
    Zeng W; Su J; Wu L; Yang D; Long T; Li D; Kuang Y; Li J; Qi M; Zhang J; Chen X
    Curr Mol Med; 2014 Jan; 14(1):163-73. PubMed ID: 24090196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD147-targeting siRNA inhibits cell-matrix adhesion of human malignant melanoma cells by phosphorylating focal adhesion kinase.
    Nishibaba R; Higashi Y; Su J; Furukawa T; Kawai K; Kanekura T
    J Dermatol; 2012 Jan; 39(1):63-7. PubMed ID: 21967109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EMMPRIN/CD147 is an independent prognostic biomarker in cutaneous melanoma.
    Caudron A; Battistella M; Feugeas JP; Pages C; Basset-Seguin N; Mazouz Dorval S; Funck Brentano E; Sadoux A; Podgorniak MP; Menashi S; Janin A; Lebbé C; Mourah S
    Exp Dermatol; 2016 Aug; 25(8):618-22. PubMed ID: 27060463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural insights on druggable hotspots in CD147: A bull's eye view.
    Kumar D; Vetrivel U; Parameswaran S; Subramanian KK
    Life Sci; 2019 May; 224():76-87. PubMed ID: 30904494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cleaved CD147 shed from the surface of malignant melanoma cells activates MMP2 produced by fibroblasts.
    Hatanaka M; Higashi Y; Fukushige T; Baba N; Kawai K; Hashiguchi T; Su J; Zeng W; Chen X; Kanekura T
    Anticancer Res; 2014 Dec; 34(12):7091-6. PubMed ID: 25503136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel treatment strategy for NRAS-mutated melanoma through a selective inhibitor of CD147/VEGFR-2 interaction.
    Landras A; Reger de Moura C; Villoutreix BO; Battistella M; Sadoux A; Dumaz N; Menashi S; Fernández-Recio J; Lebbé C; Mourah S
    Oncogene; 2022 Apr; 41(15):2254-2264. PubMed ID: 35217792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.